---
figid: PMC9372658__atm-10-14-795-f4
pmcid: PMC9372658
image_filename: atm-10-14-795-f4.jpg
figure_link: /pmc/articles/PMC9372658/figure/f4/
number: Figure 4
figure_title: ''
caption: Protein levels of TLR4, NF-κB, and TNF-α in each group. NS, normal saline;
  PTZ, pentetrazol; TLR4, toll-like receptor 4; NF-κB, nuclear factor kappa beta,
  TNF-α, tumor necrosis factor-α.
article_title: TAK-242 ameliorates epileptic symptoms in mice by inhibiting the TLR4/NF-κB
  signaling pathway.
citation: Jibo Dong, et al. Ann Transl Med. 2022 Jul;10(14):795.
year: '2022'

doi: 10.21037/atm-22-2707
journal_title: Annals of Translational Medicine
journal_nlm_ta: Ann Transl Med
publisher_name: AME Publishing Company

keywords:
- TAK-242
- epilepsy
- inflammation
- toll-like receptor 4 (TLR4)
- nuclear factor kappa beta (NF-κB)

---
